80 related articles for article (PubMed ID: 11146561)
21. Oxidized low density lipoprotein induces the cyclin-dependent kinase inhibitor p21(waf1) and the tumor suppressor Rb.
Mazière C; Marcheux V; Louandre C; Mazière JC
Biochem Biophys Res Commun; 2002 May; 293(5):1327-32. PubMed ID: 12054658
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.
Ausserlechner MJ; Obexer P; Böck G; Geley S; Kofler R
Cell Death Differ; 2004 Feb; 11(2):165-74. PubMed ID: 14576768
[TBL] [Abstract][Full Text] [Related]
23. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
24. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
[TBL] [Abstract][Full Text] [Related]
25. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH3T3 cells.
Ghosh PM; Moyer ML; Mott GE; Kreisberg JI
J Cell Biochem; 1999 Sep; 74(4):532-43. PubMed ID: 10440923
[TBL] [Abstract][Full Text] [Related]
27. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
Naderi S; Blomhoff R; Myklebust J; Smeland EB; Erikstein B; Norum KR; Blomhoff HK
Exp Cell Res; 1999 Oct; 252(1):144-53. PubMed ID: 10502407
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.
Girnita L; Wang M; Xie Y; Nilsson G; Dricu A; Wejde J; Larsson O
Anticancer Drug Des; 2000 Feb; 15(1):67-72. PubMed ID: 10888037
[TBL] [Abstract][Full Text] [Related]
29. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.
Park C; Lee I; Kang WK
Carcinogenesis; 2001 Oct; 22(10):1727-31. PubMed ID: 11577016
[TBL] [Abstract][Full Text] [Related]
30. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation.
Yen A; Williams M; Platko JD; Der C; Hisaka M
Eur J Cell Biol; 1994 Oct; 65(1):103-13. PubMed ID: 7889981
[TBL] [Abstract][Full Text] [Related]
31. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line.
Ookawa K; Tsuchida S; Adachi J; Yokota J
Oncogene; 1997 Mar; 14(12):1389-96. PubMed ID: 9136982
[TBL] [Abstract][Full Text] [Related]
32. Dibutyryl cyclic AMP-induced enhancement of RB protein degradation in human hepatoma cells.
Okamoto Y
Anticancer Res; 1999; 19(6B):5181-5. PubMed ID: 10697531
[TBL] [Abstract][Full Text] [Related]
33. Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters.
Noguera R; Triche TJ; Navarro S; Tsokos M; Llombart-Bosch A
Lab Invest; 1992 Feb; 66(2):143-51. PubMed ID: 1310513
[TBL] [Abstract][Full Text] [Related]
34. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
[TBL] [Abstract][Full Text] [Related]
35. [Immunocytologic study of light cell lines established in vitro from Ewing's sarcoma. Identification of neural markers].
Lizard-Nacol S; Justrabo E; Mugneret F; Volk C; Turc-Carel C
C R Seances Soc Biol Fil; 1988; 182(1):118-25. PubMed ID: 2972341
[TBL] [Abstract][Full Text] [Related]
36. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease.
Jang JS; Lee SJ; Choi YH; Nguyen PM; Lee J; Hwang SG; Wu ML; Takano E; Maki M; Henkart PA; Trepel JB
Oncogene; 1999 Mar; 18(10):1789-96. PubMed ID: 10086333
[TBL] [Abstract][Full Text] [Related]
37. PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
Aaltonen V; Peltonen J
Anticancer Res; 2010 Oct; 30(10):3995-9. PubMed ID: 21036713
[TBL] [Abstract][Full Text] [Related]
38. Dibutyryl cyclic AMP enhances the down-regulation of RB protein during G1 phase in the proliferating primary rat hepatocytes, but inhibits their entries into S phase and RB's phosphorylation.
Okamoto Y; Kikuchi E; Matsumoto M; Nakano H
Biochem Biophys Res Commun; 1993 Aug; 195(1):84-9. PubMed ID: 8395839
[TBL] [Abstract][Full Text] [Related]
39. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
Reed MF; Zagorski WA; Knudsen ES
J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
[TBL] [Abstract][Full Text] [Related]
40. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
J Clin Endocrinol Metab; 2003 Jul; 88(7):3021-6. PubMed ID: 12843138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
